Teva Pharmaceutical Will Appeal Against Court Ruling on Four Copaxone Patents
Teva will file an an appeal against the U.S. District Court of Delaware ruling to invalidate claims on patent infringement on Monday. The court ruled to reject four patent infrigement claims on Copaxone.